𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of tritium labelled (–)–U50,488, a selective kappa opioid agonist

✍ Scribed by Andrew Thurkauf; Brian De Gosta; Kenner C. Rice

Publisher
John Wiley and Sons
Year
1989
Tongue
French
Weight
227 KB
Volume
27
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repeated treatment with the selective ka
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors
✍ Sari Izenwasser; Jane B. Acri; Paul M. Kunko; Toni Shippenberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

U-69593, the selective -opioid agonist, was repeatedly administered in single daily injections (0.32 mg/kg) to male, Sprague-Dawley rats. Two or ten days later, the rats were euthanized and dopamine D 1 and D 2 receptors were measured using ( 3 H]SCH 23390 or [ 3 H]sulpiride, respectively, in caudat

Synthesis of tritium labelled DSP 4, a s
Synthesis of tritium labelled DSP 4, a selective noradrenaline neurotoxin
✍ Christer Sahlberg; Lars Gawell 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

DSP 4 (N-( 2-Chl oroethyl 1 -N-ethyl -2-bromobenzyl ami ne, 1) i s a neurotoxin, selective f o r neuronal noradrenaline (NAI. Tritium l a b e l l e d DSP 4 (Q) w i t h a specific a c t i v i t y o f 105 m C i / m l was prepared. The key step i n the synthesis i s a reduction o f the m i n o e s t e

Synthesis of 13C- and 2H-labelled AZD461
Synthesis of 13C- and 2H-labelled AZD4619: a selective PPARα agonist
✍ Karin Wiklund; Göran N. Nilsson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

## Conclusions The synthesis of AZD4619 included 14 steps with an overall yield of 13%. To reach the requirements of an increase in molecular weight by at least nine, both 13 C and 2 H had to be incorporated. According to our previous experiences the loss of deuterium in acidic positions necessita

Synthesis of tritium-labelled 5-chloro-2
Synthesis of tritium-labelled 5-chloro-2′,3′-dideoxy-3′-fluorouridine (935u83) - a selective anti-HIV agent
✍ John A. Hill; Donald D. Bankston 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 279 KB

## Abstract [5′‐^3^H]‐5‐Chloro‐2′,3′‐diodeoxy‐3′‐fluorouridine (1; R = [^3^H]) was prepared at a specific activity of 10.2 Ci/mmol suitable for development of a radioimmunoassay procedure. The synthetic sequence employed controlled oxidation of unlabelled 1 to the 5′‐aldehyde (2), isolation as the